Home › Research › Disparities
Wealth Disparities in End-of-Life Symptom Burden Among Older Adults
Irena Stijacic Cenzer, Kenneth E. Covinsky, Sarah H. Cross, Claire K. Ankuda, Lauren J. Hunt, Melissa D. Aldridge, Krista Lyn Harrison. JAMA Network Open, 2025-03-06
Topic: Risk, prevention and care in population studies
Plain-language summary
Of 8976 decedents (mean [SD] age, 81.3 [8.6] years; 4927 women [55.1%] women) in the cohort, 2197 (22.5%) were included in the low wealth category, 4534 (50.5%) in the medium wealth category, and 2245 (27.1%) in the high wealth category. Decedents with lower wealth had a higher prevalence of end-of-life symptoms. High symptom burden was most common in the low wealth group (800 decedents [37.0%]) vs the medium (1301 decedents [28.0%]) and high wealth (512 decedents [23.2%]) groups. Low wealth was associated with a significantly increased risk of high symptom burden vs medium wealth (adjusted risk ratio, 0.79; 95% CI, 0.73-0.87) and high wealth (adjusted risk ratio, 0.71; 95% CI, 0.63-0.79). Multimorbidity, functional impairment, and dementia were more common in the low wealth group and mediated this association, with functional impairment being the strongest mediator. Conclusions and Relevance: This cohort study found that lower wealth was associated with a higher symptom burden at the end of life, mediated in part by higher rates of multimorbidity, functional impairment, and dementia. These findings highlight the need for policies and programs to support patients with lower financial resources to improve end-of-life experiences and mitigate wealth disparities.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. This cohort study found that lower wealth was associated with a higher symptom burden at the end of life, partly mediated by higher rates of multimorbidity, functional impairment, and dementia. Reported effect size: 55.1%; 22.5%; 50.5%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cenzer, I. S., Covinsky, K. E., Cross, S. H., Ankuda, C. K., Hunt, L. J., Aldridge, M. D., et al. (2025). Wealth Disparities in End-of-Life Symptom Burden Among Older Adults. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.0201
Vancouver
Cenzer IS, Covinsky KE, Cross SH, Ankuda CK, Hunt LJ, Aldridge MD, et al. Wealth Disparities in End-of-Life Symptom Burden Among Older Adults. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.0201. PMID: 40048165.
BibTeX
@article{cenzer2025-40048165,
author = {Cenzer, Irena Stijacic and Covinsky, Kenneth E. and Cross, Sarah H. and Ankuda, Claire K. and Hunt, Lauren J. and Aldridge, Melissa D. and Harrison, Krista Lyn},
title = {{Wealth Disparities in End-of-Life Symptom Burden Among Older Adults}},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.0201},
pmid = {40048165},
url = {https://doi.org/10.1001/jamanetworkopen.2025.0201}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Of 8976 decedents (mean [SD] age, 81.3 [8.6] years; 4927 women [55.1%] women) in the cohort, 2197 (22.5%) were included in the low wealth category, 4534 (50.5%) in the medium wealth category, and 2245 (27.1%) in the high wealth category.
- Decedents with lower wealth had a higher prevalence of end-of-life symptoms.
- High symptom burden was most common in the low wealth group (800 decedents [37.0%]) vs the medium (1301 decedents [28.0%]) and high wealth (512 decedents [23.2%]) groups.
- Low wealth was associated with a significantly increased risk of high symptom burden vs medium wealth (adjusted risk ratio, 0.79; 95% CI, 0.73-0.87) and high wealth (adjusted risk ratio, 0.71; 95% CI, 0.63-0.79).
- Multimorbidity, functional impairment, and dementia were more common in the low wealth group and mediated this association, with functional impairment being the strongest mediator.
Why it matters
This cohort study found that lower wealth was associated with a higher symptom burden at the end of life, partly mediated by higher rates of multimorbidity, functional impairment, and dementia. It calls for policies and programs to support patients with lower financial resources and reduce wealth disparities in end-of-life experiences.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Study designcohort study
- Effect size55.1%; 22.5%; 50.5%
- Evidence strengthModerate
How this study scored 54/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA Network Open) |
| Journal's citation record | 2 / 4 | JAMA Network Open: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 5.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Krista Lyn Harrison: h-index 26 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40048165) |
| Free to read | 2 / 2 | Free to read |
| Total | 54 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamanetworkopen.2025.0201
- PubMed: 40048165
- Original source →
- Free full text: JAMA Network Open →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disparities from nearby years
Also tagged “palliative”
858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.